MedTrace Logo

Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.

NCT02049255 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-11-03

No results posted yet for this study

Summary

Comparison the use of marcaine and chloroprocaine in rachianesthesia for a surgical correction of inguinal hernia. Comparision between acute and chronic (3 months and 6 months) pain.

Conditions

Interventions

DRUG

Chloroprocaine

The Group "Chloroprocaine" will receive: Chloroprocaine: 50 mg in rachianesthesia

DRUG

Marcaine

The Group "Marcaine" will receive: Marcaine: 12,5 mg in rachianesthesia

Sponsors & Collaborators

  • Astes

    lead OTHER

Principal Investigators

  • Eric P Deflandre, MD, FCCP · Astes

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02049255 on ClinicalTrials.gov